McKesson Rating Increased to Buy at Bank of America (MCK)
McKesson (NYSE:MCK) traded up 1.81% on Friday, hitting $195.33. 633,075 shares of the company’s stock traded hands. McKesson has a 52 week low of $120.17 and a 52 week high of $195.89. The stock has a 50-day moving average of $188.3 and a 200-day moving average of $179.0. The company has a market cap of $45.038 billion and a P/E ratio of 35.41.
McKesson (NYSE:MCK) last announced its earnings results on Thursday, July 31st. The company reported $2.49 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.36 by $0.13. The company had revenue of $44.06 billion for the quarter, compared to the consensus estimate of $40.65 billion. During the same quarter in the previous year, the company posted $2.07 earnings per share. The company’s revenue for the quarter was up 36.7% on a year-over-year basis. On average, analysts predict that McKesson will post $10.72 earnings per share for the current fiscal year.
The company also recently declared a quarterly dividend, which is scheduled for Wednesday, October 1st. Shareholders of record on Tuesday, September 2nd will be given a dividend of $0.24 per share. This represents a $0.96 dividend on an annualized basis and a yield of 0.50%.
Other equities research analysts have also recently issued reports about the stock. Analysts at Mizuho raised their price target on shares of McKesson from $205.00 to $214.00 in a research note on Thursday. They now have a “buy” rating on the stock. Separately, analysts at FBR Capital Markets raised their price target on shares of McKesson from $200.00 to $210.00 in a research note on Thursday. They now have an “outperform” rating on the stock. Finally, analysts at Raymond James raised their price target on shares of McKesson from $210.00 to $220.00 in a research note on Tuesday, July 1st. Three equities research analysts have rated the stock with a hold rating, seven have issued a buy rating and one has issued a strong buy rating to the company. The company presently has an average rating of “Buy” and an average price target of $206.50.
McKesson Corporation delivers pharmaceuticals, medical supplies and healthcare information technologies.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.